Cariprazine - Schizophrenia and other psychoses

You are here : Home > Formulary Search > Cariprazine - Schizophrenia and other psychoses

I agree that in using this database I understand that this platform only provides guidance on local prescribing policy and that all prescribing decisions are ultimately the responsibility of the clinician.

Status 1

Red

Formulations :

Capsules

Formulary Status :

Primary Care

ASPH

RSFT

SASH

SABP

Associated Icons :

SPC

Restrictions / Comments :

Documentation

No records returned.

PAD Profile

ChemicalSubstance :

Cariprazine

Indication :

Schizophrenia and other psychoses

Group Name :

Keywords :

antipsychotics

Brand Names Include :

Reagila

Important Information :

SABP only - prescribing flowchart available via SABP.

Patient must be on highly effective contraceptive

Latest Additions Date From :

Latest Additions Date To :

Guidelines :

Supporting Documents :

Other Indications

Below are listed other indications that Cariprazine is used to treat.

No records returned.

Other Drugs

Below are listed other drugs that are used to treat Schizophrenia and other psychoses.

Committee Recommendations (1)

12 Nov 18 - Not Set

This drug has not yet been evaluated by the Surrey and Sussex Prescribing Clinical Network (PCN). As such, advice regarding safety, effectiveness (including cost-effectiveness) and its place in therapy is yet to be determined.

This drug is currently not on the PCN workplan. The PCN will consider recommending prescribing of this treatment upon submission of a formal request with its associated evidence. Please contact your local CCG Medicines Management team formulary pharmacist or chief pharmacist at your acute trust, if you wish to make a submission.

If asked to prescribe, please contact a member of your Medicines Management Team